Denali Therapeutics Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · South San Francisco, CA
DNLI chart
What traders are saying about $DNLI
Latest postsDenali Therapeutics Inc. news
- Guggenheim reaffirms top pick in Biotech after Q3 results
Yahoo Finance ·
- Denali Therapeutics Inc. (4DN.F) stock price, news, quote and history
Yahoo Finance UK ·
- Denali Therapeutics Inc. (DNLI) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Denali Therapeutics Stock Price Forecast. Should You Buy DNLI?
StockInvest.us ·
- Denali Therapeutics Inc. (DNLI) Seasonal returns chart
Yahoo Finance Australia ·
- Should Earnings Beat Require Action From Denali Therapeutics Stock Investors?
Yahoo Finance ·
- Denali Therapeutics (DNLI) Stock Looks Fairly Valued After Recent Gains
Simply Wall St ·
- Is Denali Therapeutics (DNLI) Already Priced Right For Its Cash Flow?
Yahoo Finance ·
- Denali Therapeutics (DNLI) Earnings Beat Puts Valuation Back In Focus
Yahoo Finance ·
- DNLI Up 7.8% Post Q3 Earnings: Should You Buy, Sell or Hold the Stock?
Yahoo Finance ·
- Denali Therapeutics Price Target Maintained With a $39.00/Share by BTIG
Moomoo ·
- Denali Therapeutics Stock Earnings Beat Has The Bull Case Changed?
Simply Wall St ·
Denali Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $330.5M | $105.1M |
| Net income | -$512.5M | -$422.8M | -$145.2M | -$326.0M |
| Diluted EPS | $-2.97 | $-2.57 | $-1.06 | $-2.60 |
| Total assets (year end) | $1.14B | $1.37B | $1.15B | $1.46B |
| Cash and equivalents (year end) | $205.3M | $175.0M | $127.1M | $218.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Denali Therapeutics Inc.
- Ticker
- DNLI (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1714899
Frequently asked questions
What exchange is Denali Therapeutics Inc. listed on?
Denali Therapeutics Inc. trades on the Nasdaq under the ticker symbol DNLI.
What industry is Denali Therapeutics Inc. in?
Denali Therapeutics Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Denali Therapeutics Inc. headquartered?
Denali Therapeutics Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Denali Therapeutics Inc.'s fiscal year end?
Denali Therapeutics Inc.'s fiscal year ends on December 31.
How much revenue did Denali Therapeutics Inc. report?
Denali Therapeutics Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.